Follow

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Follow
LinkedIN Twitter Instagram Youtube
Contact
LinkedIN Twitter Instagram Youtube

SFDA approves registration of ‘Anktiva’ for treatment of bladder and lung cancer

by
January 17, 2026
SFDA approves registration of ‘Anktiva’ for treatment of bladder and lung cancer SFDA approves registration of ‘Anktiva’ for treatment of bladder and lung cancer

Saudi Gazette reportRIYADH — The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva (nogapendekin alfa inbakicept) in combination with immunotherapy for adult patients

by
Updated
Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement

Read more